{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Schmidt-Hellerau K"],"funding":["Universitätsklinikum Köln","German Federal Joined Committee"],"pagination":["1407-1414"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11289149"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["52(4)"],"pubmed_abstract":["<h4>Purpose</h4>Outpatient parenteral antimicrobial therapy (OPAT) offers several key advantages, including enhanced patient quality of life, reduced healthcare costs, and a potential reduction of nosocomial infections. It is acknowledged for its safety and effectiveness. This study provides the first systematic clinical data for Germany, where OPAT has not yet been widely adopted. The aim is to establish a foundational reference point for further research and integration of OPAT into the German healthcare system.<h4>Methods</h4>This prospective observational study descriptively analyses data obtained from a cohort of patients receiving OPAT. Both in- and outpatients from all medical specialties could be recruited. Patients administered the anti-infective medications themselves at home usi"],"journal":["Infection"],"pubmed_title":["Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study."],"pmcid":["PMC11289149"],"funding_grant_id":["01VSF18036"],"pubmed_authors":["Peter S","Kupper-Nybelen J","Gunther M","Scholten N","Lindemann CH","Suarez I","Horn C","Schmidt-Hellerau K","Oberrohrmann C","Ihle P","Hagemeier A","Baade N","Hellmich M","Jung N","Lehmann C","Leisse C"],"additional_accession":[]},"is_claimable":false,"name":"Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study.","description":"<h4>Purpose</h4>Outpatient parenteral antimicrobial therapy (OPAT) offers several key advantages, including enhanced patient quality of life, reduced healthcare costs, and a potential reduction of nosocomial infections. It is acknowledged for its safety and effectiveness. This study provides the first systematic clinical data for Germany, where OPAT has not yet been widely adopted. The aim is to establish a foundational reference point for further research and integration of OPAT into the German healthcare system.<h4>Methods</h4>This prospective observational study descriptively analyses data obtained from a cohort of patients receiving OPAT. Both in- and outpatients from all medical specialties could be recruited. Patients administered the anti-infective medications themselves at home usi","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Aug","modification":"2026-05-29T10:11:23.371Z","creation":"2026-04-08T04:24:59.783Z"},"accession":"S-EPMC11289149","cross_references":{"pubmed":["38478255"],"doi":["10.1007/s15010-024-02199-9"]}}